-
The Potential Long-Term Comparative Effectiveness of Larotrectinib vs Repotrectinib for Treatment of NTRK Gene Fusion-Positive Cancers
Mar 10, 2025, 14:00 PM -
From Short-Term Relief to Long-Term Benefits: Tracking the Impact of Insulin Pumps on Fear of Hypoglycemia in people with Type 1 Diabetes Mellitus
Mar 10, 2025, 14:00 PM -
Private Insurance May Fail to Protect Against Healthcare Financial Hardship, Evidence from the 2018 and 2019 Medical Expenditure Panel Survey
Mar 10, 2025, 14:00 PM -
Estimating Quality-Adjusted Life Years and Life-Years Gained in Glioblastoma Patients: Analysis from the TIGER Trial
Mar 10, 2025, 14:00 PM -
Cost Effectiveness of ICD Therapy for 1.5 Primary Prevention in the Dominican Republic
Mar 10, 2025, 14:00 PM -
Utilization of Adalimumab and Infliximab Biologics and Biosimilars in Rheumatoid Arthritis Patients
Mar 10, 2025, 14:00 PM -
Validation of a Flexible Partitioned Survival and 3-State Markov Model for Cost-Effectiveness Analyses in Oncology
Mar 10, 2025, 14:00 PM -
Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay
Mar 10, 2025, 14:00 PM -
Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer
Mar 10, 2025, 14:00 PM -
Sociodemographic Determinants and Inequities in Prenatal Healthcare in the Canadian Province of Manitoba: A Population-Based Cohort Study 2010-2022
Mar 10, 2025, 14:00 PM -
Experiences of Hungarian Mothers About Breastfeeding Support From Health Visitors
Mar 10, 2025, 14:00 PM -
Aggressive End-of-Life Care among Non-Small Cell Lung Cancer Medicare Patients
Mar 10, 2025, 14:00 PM -
Developing a Conceptual Framework for a De-novo Cost-Effectiveness Model in Sanfilippo Syndrome (MPSIIIA)
Mar 10, 2025, 14:00 PM -
Preparing for German Health Technology Assessment: Analysis of Factors Associated with the Risk of Having Inappropriate Comparator
Mar 10, 2025, 14:00 PM -
Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncology Clinics
Mar 10, 2025, 14:00 PM -
Impact of the X-Waiver Elimination on Buprenorphine Prescribing by Non-Physician Clinicians: An Interrupted Time Series Analysis
Mar 10, 2025, 14:00 PM -
Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective
Mar 10, 2025, 14:00 PM -
Development and Validation of a Machine Learning-Based Prediction Model for 30-Day COPD Readmissions: Enhancing Early Risk Stratification and Intervention
Mar 10, 2025, 14:00 PM -
Association between Socioeconomic Factors and Guideline-Directed Medical Therapy (GDMT) Utilization Among Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction (HFrEF)
Mar 10, 2025, 14:00 PM -
Operationalizing an Outcomes-Based MarketAccess Agreement Using Real-World Data From the Canadian Neuromuscular Disease Registry
Mar 10, 2025, 14:00 PM